Tagged with RTS

Singapore The ongoing COVID-19 pandemic is a double-edged sword for Singapore. While its economy has been hit by the global crisis, the island city-state is seeing an uptick in pharmaceutical manufacturing exports to countries looking to stock up on active pharmaceutical ingredients (APIs).   Singapore’s pharmaceutical output has jumped 86 percent…

Belgium Stakeholders from the Belgian parallel trade industry outline how their activities are helping to solve medicine shortages in Europe and ensure patients have access to the medicines they need. They also tackle some of the criticisms often levelled at parallel distributors and foreground the industry’s vital importance for Belgian, and…

Belgium Tanguy Schmitz, president of the Belgian Association of Parallel Importers & Exporters (BAPIE) outlines some of the recent work that the parallel distribution industry to ensure the supply of medicines across Belgium and Europe during the COVID-19 pandemic, rebuffs some of the negative stereotypes that the industry has garnered, and…

Belgium Filip Van de Vliet and Gérard Lefèbvre of Alter Pharma Group discuss the value that parallel importing is bringing to Belgian patients and the evolving relationship between parallel importers and the wider pharma industry. They also offer insights into Alter Pharma’s planned launch of generic medicines in the US market…

UAE Located in the heart of the UAE, Dubai Airports owns and manages the operation and development of both of the city’s airports, Dubai International (DXB) and Dubai World Central (DWC). Jochen Schnadt, VP of Aviation Business Management, explains why the pharmaceutical industry has been a success story within the special…

Medtech Global medtech giant Medtronic manages a highly diverse region that spans both developed and developing markets from its UAE offices. The firm continues to see growth potential in both types of markets, as well as abundant opportunities to improve outcomes for potentially millions of patients through its technologies.   Diverse…

Hungary Katinka Zinnemers, managing director of Abacus Medicine, highlights the company’s mission to increase access to medicines for all patients and its commitment to building trust with authorities as it enters into the arena of parallel imports.     As a parallel trade company, we must be compliant in the same manner…

UAE The UAE pharma market is projected to grow over 80 percent by 2027, in part due to a growing demand for the treatment of lifestyle diseases and expansion of comprehensive health insurance.  Made with Visme Presentation Maker     Pharmaceutical imports into the UAE come from 72 countries. 80 percent…

Thailand Suthep Namwongsamran, GM of M&H Manufacturing, provides insights into the distinctive model that has allowed M&H to become one of Thailand’s leading domestic pharmaceutical manufacturers. He also outlines the expected development of the M&H’s international strategy and his focus on bringing biosimilars to Thailand via mutually beneficial partnerships.   We…

Sweden Orifarm is the largest supplier of parallel imported medicines in the EU and a fast-growing supplier of generic pharmaceuticals in the Nordic countries. Christian Vallentin, country manager of Orifarm Sweden, explains the intricacies of the parallel import business and generics market in Sweden, how to successfully compete in both areas,…

Sweden Sweden’s pharmaceutical exports shot up 27% in first quarter 2019, continuing an upward growth trend in an industry that is increasingly well-renowned internationally for its quality and high technology.   The Swedish healthcare and life sciences sector enjoys a good reputation abroad and is strongly associated with quality and innovation…

Egypt Ashraf Osman, president and CEO of AUG Pharma, explains how his company has become one of Egypt’s Top 30 pharmaceutical companies in less than four years of manufacturing, gives an insight into the branding strategy of an industry newcomer, and outlines the company’s export strategy.   In 2018 alone we…